Hundreds of women with hard-to-treat ovarian cancer could benefit from a new, life-extending drug on the NHS from today – the first new addition to NHS treatment in over 20 years. The new targeted therapy – mirvetuximab soravtansine – will be offered to patients living with ovarian cancer whose disease has stopped responding to standard […]
Follow NHS England's news and updates in a matter of seconds! We will deliver any update via email, phone or you can read them from here on the site on your own news page.
You can even combine different feeds with the feed for NHS England.
Subscribing and unsubscribing is fast, easy and risk free.
The whole service is free of cost.
NHS England: NHS England